QCast: Data-Driven Dialogue in Drug Development

Episode 47: The Creation of ADaM Datasets for PK Analysis

In this QCast episode, Jullia and Tom discuss how ADaM datasets are created for pharmacokinetic, or PK, analysis. They look at the role of ADPC for concentration data and ADPP for derived PK parameters, including how these datasets relate to SDTM PC and PP. The episode also covers why timing, dosing information, analysis values, flags and study-specific rules matter when preparing PK data for reporting and review. Key Takeaways * ADPC supports PK concentration data, while ADPP supports derived PK parameters such as Cmax, Tmax, AUC and half-life. Both datasets help turn PK data into an analysis-ready structure. * PK results depend on the relationship between dosing and sample collection. Planned and actual time points, relative time variables and pre-dose samples all need careful handling. * Analysis values, flags and criteria variables help show which records were analysed, which were excluded and why. This makes PK outputs easier to review and reproduce. 🔗 Learn More & Get Support: Visit quanticate.com [https://quanticate.com] to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast [https://quanticate.com/podcast]. 🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: * Clinical Data Capture & Management * Biostatistics & Statistical Consultancy * Statistical Programming & PK/PD Analysis * Medical Writing & Pharmacovigilance * Regulatory & Submission Support * AI & Automation * Post-Marketing Safety & Real-World Data Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

Episode 46: What is Clinical Data Review?

In this QCast episode, Jullia and Tom discuss clinical data review as an active part of study oversight, rather than a late-stage clean-up exercise. They explore how timely, connected review supports subject safety, data quality, medical review and confident decision-making, especially as trial data now comes from EDC, ePRO, eCOA, labs, imaging, biomarkers, wearables and other sources. Key Takeaways * Good review helps teams spot patterns, missing context and signals that may affect trial conduct or subject safety before issues become embedded. * A lab result, adverse event or dosing change becomes more useful when it can be reviewed alongside related data at the right point in the study. * Dashboards, alerts and automation can help focus attention, but teams still need clear ownership, escalation routes, traceability and risk-based priorities. 🔗 Learn More & Get Support: Visit quanticate.com [https://quanticate.com] to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast [https://quanticate.com/podcast]. 🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: * Clinical Data Capture & Management * Biostatistics & Statistical Consultancy * Statistical Programming & PK/PD Analysis * Medical Writing & Pharmacovigilance * Regulatory & Submission Support * AI & Automation * Post-Marketing Safety & Real-World Data Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

Episode 45: Clinical Trial Management Systems (CTMS)

In this QCast episode, Jullia and Tom discuss clinical trial management systems and their role in keeping clinical studies under control. They explain how CTMS differs from EDC, why operational visibility matters across recruitment, monitoring, site activity and documentation, and how a well-used system can support risk-based oversight, audit trails and better decision-making across sponsors, CROs and sites. Key Takeaways * A CTMS gives study teams a central view of milestones, site activation, monitoring activity, recruitment, documents, payments and follow-up actions. * When CTMS connects with systems such as EDC, eTMF, safety platforms and finance tools, teams can reduce duplicate entry and work from a more reliable operational picture. * The right CTMS should reflect real trial workflows, support current guidance expectations around oversight, and help teams act earlier when risks or delays appear. 🔗 Learn More & Get Support: Visit quanticate.com [https://quanticate.com] to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast [https://quanticate.com/podcast]. 🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: * Clinical Data Capture & Management * Biostatistics & Statistical Consultancy * Statistical Programming & PK/PD Analysis * Medical Writing & Pharmacovigilance * Regulatory & Submission Support * AI & Automation * Post-Marketing Safety & Real-World Data Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

Episode 44: Clinical Trial Simulation

In this QCast episode, co-hosts Jullia and Tom explore clinical trial simulation and how it supports better study design decisions before a trial begins. They explain how simulation uses statistical and mathematical models to test plausible study scenarios, rather than relying on a single fixed assumption. Key Takeaways * Simulation helps teams see how a study design may behave under different assumptions around treatment effect, variability, dropout, recruitment, or safety. * The right model depends on the question, whether that is dose selection, endpoint choice, interim planning, or operational feasibility. * Simulation is most useful when scenarios reflect clinical and operational reality, with clear assumptions, verification, and communication. 🔗 Learn More & Get Support: Visit quanticate.com [https://quanticate.com] to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast [https://quanticate.com/podcast]. 🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: * Clinical Data Capture & Management * Biostatistics & Statistical Consultancy * Statistical Programming & PK/PD Analysis * Medical Writing & Pharmacovigilance * Regulatory & Submission Support * AI & Automation * Post-Marketing Safety & Real-World Data Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.

Episode 43: Clinical Study Start Up

In this QCast episode, co-hosts Jullia and Tom explore clinical study start up and why it has such a direct effect on how a trial runs once sites begin opening. They look at what study start up actually includes, from feasibility and budgeting to contracts, ethics, and regulatory submissions, and explain why early choices in this phase can shape timelines, site activation, and the amount of operational disruption carried into enrolment. Key Takeaways * Feasibility should test whether the study can really run as planned. That means looking beyond protocol intent to site capacity, patient availability, staffing, and day-to-day operational burden. * Delays in study start up do not come only from ethics or regulatory review. Budget development, contract negotiation, handoffs, and unclear ownership can quietly add significant waiting time. * Start up becomes more predictable when teams treat it as a controlled process. Clear accountability, parallel work where appropriate, and measurement of cycle time and delays all help reduce avoidable slowdowns. 🔗 Learn More & Get Support: Visit quanticate.com [https://quanticate.com] to explore our biometrics services and discover how we can support your next clinical trial. 📝 Episode Notes & Transcript: Find show notes, resources, and a full transcript at quanticate.com/podcast [https://quanticate.com/podcast]. 🔔 Stay Connected: Subscribe to QCast on Apple Podcasts, Spotify, or your favourite platform to never miss an episode. About Quanticate Founded in 1994, Quanticate is a biometrics-focused CRO with over 30 years' experience delivering expert clinical and post-marketing data services worldwide. Specialising in the collection, management, standardisation, analysis, and reporting of data, we support pharma and biotech companies globally with high-quality solutions for clinical development. We specialise in: * Clinical Data Capture & Management * Biostatistics & Statistical Consultancy * Statistical Programming & PK/PD Analysis * Medical Writing & Pharmacovigilance * Regulatory & Submission Support * AI & Automation * Post-Marketing Safety & Real-World Data Quanticate is committed to delivering expertise and solutions that drive the success of clinical development worldwide.